Nanoviricides Inc NNVC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NNVC is a good fit for your portfolio.
News
-
COVID is Here to Stay and NV-387 is a Much Needed Drug Against It, Reminds NanoViricides
-
A Single Drug Against Multiple Respiratory Virus Infections - COVID, RSV, Influenza, Bird Flu - Planning Next Phase of Clinical Trials, Says NanoViricides
-
NanoViricides is Well Positioned with Its Clinical and Pre-Clinical Pipeline and Unique Host-Mimetic, Virus Killing, Technology Platform Intending To Revolutionize Treatment of Viral Infections
-
A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Could Be an Important Weapon to Fight Bird Flu H5N1, Says NanoViricides
-
A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Is Effective in Protecting Lungs from Damage in Lethally Infected Animal Model
-
Orally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral Effect
-
The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for Strong Antiviral Effect
-
A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More
Trading Information
- Previous Close Price
- $2.20
- Day Range
- $2.16–2.35
- 52-Week Range
- $1.00–3.59
- Bid/Ask
- $2.15 / $2.33
- Market Cap
- $26.46 Mil
- Volume/Avg
- 162,133 / 346,491
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 7
- Website
- http://www.nanoviricides.com
Valuation
|
Metric
|
NNVC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.48 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
NNVC
|
|---|---|
Quick Ratio | 4.00 |
Current Ratio | 4.32 |
Interest Coverage | −196.78 |
Quick Ratio
NNVC
Profitability
|
Metric
|
NNVC
|
|---|---|
Return on Assets (Normalized) | −61.27% |
Return on Equity (Normalized) | −67.11% |
Return on Invested Capital (Normalized) | −67.76% |
Return on Assets
NNVC
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk A/S ADR
NVO
| Hctfqqwjq | Vcknn | $565.6 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Pdnbbjq | Phppr | $127.8 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Ljpjvxvkb | Pkcpfh | $118.7 Bil | |||
| Moderna Inc
MRNA
| Dzyhyqyb | Fqtq | $46.8 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Hwtrrfzv | Dkjqvzv | $29.7 Bil | |||
| argenx SE ADR
ARGX
| Sjyctwlp | Rgxq | $29.3 Bil | |||
| BioNTech SE ADR
BNTX
| Dzvwxnxj | Ljjw | $20.7 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Hcwvffhgb | Glggdh | $16.1 Bil | |||
| United Therapeutics Corp
UTHR
| Nfxcdtxq | Bfpml | $15.0 Bil | |||
| Incyte Corp
INCY
| Rjqdmhly | Pzzgyk | $13.5 Bil |